Mandate

Vinge advises Lassie AB in its SEK 115 million financing round

May 24, 2022

Vinge has advised the pet insurance company Lassie AB in connection with a SEK 115 million financing round for the purpose of expanding the business internationally and developing the company’s app.

Lassie AB, whose business model incentivises the users to reduce their insurance costs by gaining points through preventive veterinary care, was founded by Hedda Båverud Olsson, Johan Jönsson and Sophie Wilkinson and the company has grown rapidly since its first financing round less than a year ago.

The financing round was led by the British venture capital firm, Felix Capital, and involved several current investors, among others, the institutional investors Inventure and Passion Capital as well as H&M’s chairman of the board, Karl-Johan Person, and Voi’s founder and head of marketing, Fredrik and Caroline Hjelm.

Vinge’s team consisted of Filip Öhrner, Maria Dahlin Kolvik and Viktor Lennartsson.

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026